U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06858527) titled 'Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment' on Feb. 27.
Brief Summary: Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUDs) is a highly common comorbid condition associated with serious medical and psychosocial consequences. However, and despite the international consensus recommending integrated treatment for this comorbidity, few studies tested the efficacy of specific psychotherapeutic treatment for this comorbidity.
The aim of this study is to test the efficacy of a specific group Cognitive and Behavioral Therapy (CBT) for the treatment of adults wit...